United Therapeutics Chairperson and CEO Martine A. Rothblatt reports $5.59 million common-share sale
Bitget2026/10/27 20:48- United Therapeutics Chairperson and CEO Martine A. Rothblatt sold 9,500 common shares on Oct. 26, 2026.
- Sales were reported at weighted-average prices ranging from $585.7122 to $592.9168 per share.
- Rothblatt also exercised stock options for 9,500 common shares at $117.76 per share.
- The transactions left 324,443 common shares held indirectly through trusts involved in the trades; direct holdings totaled 40,513 shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Honda Motor (HMC.US) Reports 65.7% Increase in Net Profit in the First Half, Plans to Expand Production Capacity in North America and Brazil
Honda Motor (HMC.US) released its financial results for the first half of fiscal year 2027 on November 10.
Crypto winter not over? Mining rig hosting provider Bitari cancels orders at the last minute, IPO plans put on hold
Bitcoin mining service provider Bitari has withdrawn its Nasdaq IPO plan. The company originally intended to issue 4.3 million shares at $7 per share to raise $30 million. Its annual revenue is approximately $11 million.
Pre-orders for GTA 6 are booming and may reverse the downward trend! Citigroup raises Take-Two Interactive Software (TTWO.US) target to $270
Citigroup maintains a "Buy" rating on Take-Two Interactive Software, with a target price of $270.
Crypto prices
More
